Journal Information
Vol. 31. Issue 12.
Pages 833-834 (December 2012)
Share
Share
Download PDF
More article options
Vol. 31. Issue 12.
Pages 833-834 (December 2012)
Image in cardiology
Open Access
Becker's muscular dystrophy cardiomyopathy: Insights from imaging modalities
Cardiomiopatia na distrofia muscular de Becker: Perceções das modalidades de imagem
Visits
5306
Miguel Silva Vieiraa, Peter Drivasb, Raad H. Mohiaddinb,c
a Cardiology Department, Hospital Santo António – Centro Hospitalar do Porto, Porto, Portugal
b Royal Brompton & Harefield NHS Foundation Trust, London, UK
c National Heart & Lung Institute, Imperial College London, London, UK
This item has received

Under a Creative Commons license
Article information
Full Text
Download PDF
Statistics
Figures (1)
Full Text

A 16-year-old male patient with known Becker's muscular dystrophy (BMD), with deletion of exon 48–49, was noted to have recent deterioration in already limited functional capacity. The transthoracic echocardiogram revealed moderately impaired left ventricular systolic function, with ejection fraction of 44% (Figure 1A), and preserved relaxation (Figure 1B). A cardiovascular magnetic resonance (CMR) study was performed and confirmed high-normal indexed left ventricular volumes with moderately reduced global ejection fraction (48%). No active inflammation was seen. Late gadolinium-enhanced images showed typical subepicardial fibrosis of the lateral and inferior wall from base to mid-ventricular level (Figure 1C and D).

Figure 1.

(A) Transthoracic echocardiogram in parasternal view depicting a dilated left ventricle with moderately reduced ejection fraction. (B) Tissue Doppler imaging of lateral mitral inflow velocities, with an E/e′ ratio of 5.3, suggestive of normal filling pressures. (C and D) Cardiovascular magnetic resonance images with late gadolinium enhancement showing typical subepicardial inferolateral fibrosis (white arrows), also involving the mid-septum (dashed arrow), consistent with Becker's cardiomyopathy.

(0.2MB).

BMD is an X-linked inherited progressive myopathic disorder caused by mutations in the dystrophin gene; the dystrophin protein plays an essential role in signal pathways and stabilization of the cardiomyocyte cell membrane. It is characterized by proximal skeletal muscle weakness and wasting. Cardiac muscle can be affected, with degeneration of fibers, replacement fibrosis and fatty infiltration. The pathophysiology is not entirely understood; it is postulated that diffuse myocardial metabolic abnormalities lead to fibrosis, starting, as in this patient, in the subepicardium of the inferolateral wall, due to greater mechanical stress in this region. Progressive cardiomyopathy, often subclinical in the early stages, is a major cause of morbidity and mortality. Advanced echocardiographic assessment of diastolic function and tissue characterization by CMR enable early detection of cardiac involvement and timely initiation of heart failure treatment to prevent ventricular remodeling.

Ethical disclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this investigation.

Confidentiality of data

The authors declare that they have followed the protocols of their work center on the publication of patient data and that all the patients included in the study received sufficient information and gave their written informed consent to participate in the study.

Right to privacy and informed consent

The authors have obtained the informed consent of the patients and/or subjects mentioned in the article. The corresponding author is in possession of this document.

Conflict of interest

The authors have no conflicts of interest to declare.

Copyright © 2012. Sociedade Portuguesa de Cardiologia
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.